FDA
approval
· 2025-04-29
FDA Approved: ZELVYSIA — Original Application (Aucta Pharmaceuticals, Inc.)
Summary
The FDA approved Zelvysia (sapropterin dihydrochloride) via an original Abbreviated New Drug Application from Aucta Pharmaceuticals, Inc. for the treatment of p…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ZELVYSIA (SAPROPTERIN DIHYDROCHLORIDE)